eHealth, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by eHealth, Inc. on March 21, 2012. The filing reports significant changes in executive leadership and board composition effective late March and early April 2012.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margin, debt, or liquidity metrics. The document focuses exclusively on executive compensation arrangements and personnel changes.
Material Changes
Executive Appointments:
- Bill Shaughnessy was appointed President and Chief Operating Officer, effective March 27, 2012.
- Mr. Shaughnessy was simultaneously appointed to the Board of Directors as a Class II director, with a term expiring in 2014. He will receive no compensation for board service.
Executive Departures:
- Bruce A. Telkamp (Executive Vice President of Business and Corporate Development) and Dr. Sheldon X. Wang (Executive Vice President of Technology and Chief Technology Officer) are departing effective April 2, 2012.
Compensation and Contractual Terms
Bill Shaughnessy Employment Agreement:
- Base Salary: $500,000 annually.
- Performance Bonus: Eligible for an annual bonus of at least 60% of base salary (pro-rated for the first partial year).
- Signing Bonus: Up to $225,000, subject to repayment if employment is terminated for cause or voluntarily (other than for good reason) within two years.
- Equity Awards (Grant Date: April 17, 2012):
- Stock Options: 400,000 shares vesting 20% on the first anniversary and monthly thereafter over five years.
- Restricted Stock Units (RSUs): 25,000 shares vesting 25% annually over four years.
- Change of Control Provisions: In the event of termination without cause or voluntary termination for good reason during the Change of Control Period, Mr. Shaughnessy is entitled to 12 months' base salary, a pro-rated bonus, $36,000 for COBRA, and 100% acceleration of equity vesting. Outside this period, he receives 12 months' continued salary, 12 months' COBRA payments ($3,000/month), and 12 months' equity vesting acceleration.
Investor Verification Checklist
- Verify the impact of the departure of the Chief Technology Officer and Executive Vice President of Business Development on ongoing product development and strategic initiatives.
- Confirm the total cost of the new executive compensation package, including the $225,000 signing bonus and equity grants, against the company's current cash position.
- Review the referenced press release (Exhibit 99.1) for details regarding the reasons for the departures of Mr. Telkamp and Dr. Wang.
- Monitor the integration of Mr. Shaughnessy's background in digital media and advertising (Yahoo!, Microsoft) into eHealth's business model.